despite the use of different measures of depressive difference between community symptoms and falls and varying length of follow-up samples and those with identified and statistical methods. healthcare needs with respect to depressive symptoms being a risk factor for falls. Item Evidence details Reference Nil Nil Interventions 10.7.1 Further No further Item Evidence details Reference 10.7.1 Establish a baseline Identifying the presence of cognitive impairment ABPG p37 Further No further cognitive screen. For should form part of the falls risk assessment example the process. abbreviated Mental Test (AMT) or as per local guidelines. Think of cognition as another vital sign that needs ABWTC Item Evidence details Reference Establish a baseline screen e.g. Abbreviated Test (AMT) or as per local 10.7.1 Further No further to be monitored. (clinicians) p5 The score for an abnormal result Item Evidence details Reference Further 10.7.1 If result abnormal (e.g. The screening tool is not expected to diagnose, but ABWTC(9) will depend the tool/s in use at AMT <8) refer to OT or to detect cognitive impairment and to trigger further (Managers) each site. For instance for the AMT MO for prompt review. investigation and action. p40 4 any score <4 will be abnormal and a trigger for further review. Treat medical conditions that may contribute to an ABPG p51 Item Evidence details Reference Further If result (e.g. AMT <8) to OT or MO for 10.7.1 The score for an abnormal result will depend the tool/s use at each site. For for the AMT 4 any score <4 will be abnormal and a trigger for further alteration in cognitive status. Older patients with a progressive decline in ABPG p51 Item Evidence details Reference Further If result (e.g. AMT <8) to OT or MO for 10.7.1 The score for an abnormal result will depend the tool/s use at each site. For for the AMT 4 any score <4 will be abnormal and a trigger for further cognition should undergo a detailed assessment
despite the use of different measures of depressive symptoms and falls and varying length of follow-up and statistical methods. difference between community samples and those with identified healthcare needs with respect to depressive symptoms being a risk factor for falls. Item Interventions 10.7.1 Evidence details Nil Reference Nil Further No further Item Establish a baseline cognitive screen. For example the abbreviated Mental Test (AMT) or as per local guidelines. 10.7.1 Evidence details Identifying the presence of cognitive impairment should form part of the falls risk assessment process. Reference ABPG p37 Further No further Item Establish a baseline screen e.g. Abbreviated Test (AMT) or as per local 10.7.1 Evidence details Think of cognition as another vital sign that needs to be monitored. Reference ABWTC (clinicians) p5 Further No further Item If result abnormal (e.g. AMT <8) refer to OT or MO for prompt review. 10.7.1 Evidence details The screening tool is not expected to diagnose, but to detect cognitive impairment and to trigger further investigation and action. Reference ABWTC(9) (Managers) p40 Further The score for an abnormal result will depend the tool/s in use at each site. For instance for the AMT 4 any score <4 will be abnormal and a trigger for further review. Item If result (e.g. AMT <8) to OT or MO for 10.7.1 Evidence details Treat medical conditions that may contribute to an alteration in cognitive status. Reference ABPG p51 Further The score for an abnormal result will depend the tool/s use at each site. For for the AMT 4 any score <4 will be abnormal and a trigger for further Item If result (e.g. AMT <8) to OT or MO for 10.7.1 Evidence details Older patients with a progressive decline in cognition should undergo a detailed assessment Reference ABPG p51 Further The score for an abnormal result will depend the tool/s use at each site. For for the AMT 4 any score <4 will be abnormal and a trigger for further
FRAMP-Evidence-table-acc.docx